Skip to content
PreclinicalResearch compoundLimited evidence

Imidazenil

Experimental anti-anxiety compound: less sedating than diazepam in animals, never studied in humans.

AnxiolyticImidazobenzodiazepineAnxiolyticSleep/AnxietyGABA

Pharmacology

ClassAnxiolytic · Sleep/Anxiety
Primary targetGABA-A benzodiazepine site partial agonist
Targets4 receptor targets
Half-lifeNo reliable human pharmacokinetic data
OnsetNo human data
EvidenceLimited evidence
Affected systemsGABA

Contents

DETAILED OVERVIEW

What is Imidazenil?

Imidazenil is an experimental anti-anxiety compound, related to benzodiazepine-type sedatives such as diazepam. It has not been approved as a medicine anywhere and was never marketed for human use; it exists as a laboratory research compound, not intended for human consumption.

It acts on the same calming brain system (GABA) as benzodiazepines but strengthens it only partially. In animals it was much less sedating than diazepam while still easing anxiety and seizures. In animal models of nerve-agent poisoning it showed anticonvulsant and protective effects on nerve cells, with no tolerance developing to these effects; in mice it also eased behavior changes caused by social isolation. It has not been studied in humans, so there is no data on its safety or its potential for tolerance and withdrawal. Combined with other substances that slow the central nervous system (alcohol, opioids, benzodiazepines), the effects could in theory add up. Safety in pregnancy and breastfeeding has not been established.

Mechanism

GABA-A benzodiazepine-site partial agonist

Evidence

Preclinical only (no human data)

Legal status

Unapproved research compound

Receptor profile

  • Benzodiazepine site (GABA-A)Strong
  • GABA-A alpha5 subunit (fuller agonism)Strong
  • GABA-A alpha1 subunit (weak, low sedation)Weak
  • Tolerance / dependence liabilityModerate

Safety

Side effects, stop signs, contraindications

Side effects · 5

  • No human safety data: only preclinical (rodent and guinea pig) studies exist; the compound has never been registered in humans
  • Reduction of locomotor activity at higher doses
  • Benzodiazepine class effects (sedation, incoordination) cannot be excluded in principle, though much milder than diazepam in animals
  • As a partial agonist, unknown human tolerance and withdrawal profile
  • Unknown long-term safety and incomplete toxicology profile in humans

Contraindications · 4

  • Pregnancy and breastfeeding: safety not established, avoid
  • Other CNS depressants (alcohol, opioids, other benzodiazepines): theoretical risk of additive effects
  • Benzodiazepine hypersensitivity or prior substance-use disorder
  • Not an approved medicine; experimental research compound, not recommended without clinical supervision

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Imidazenil is an experimental compound studied mainly for anticonvulsant and anxiety-easing effects, with the notable feature that it's less sedating than traditional drugs that work through a similar mechanism. In animal studies it also showed a protective effect on nerve cells during poisoning, and its effects didn't fade over time. Like the others in this class, it's still at the preclinical, animal-study stage only, with no human data.

Telegram

Have a question about Imidazenil?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeAnxiolytic
FormulaC18H12BrFN4O
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.